You are here: Home > Institute of Excellence (CPD) > Calendar > CPD Events > WAVE@home – AMD – Imaging, Classification and Advanced Therapeutics

WAVE@home - AMD - Imaging, Classification and Advanced Therapeutics

Available from: 9/04/2020

Where to publish: Optometry Australia Institute - Launch Course Below

Provider: Optometry WA

Contact: Optometry WA Office, [E], [P] (08) 9321 2300

Learning Objectives

  • 1. Review the Beckman classification of age-related macular degeneration.
  • 2. Understand how the Beckman classification can provide information on risk of progression, and direct appropriate patient management.
  • 3. Understand the limitations of the Beckman classification scheme and learn about emerging schemes (including the use of optical coherence tomography imaging) will be presented and applied to clinical scenarios.
  • 4. Be able to identify common clinical presentations on optical coherence tomography, infrared images, and autofluorescence images (for example, early AMD, intermediate AMD, geographic atrophy and neovascular AMD)
  • 5. Learn about new imaging biomarkers, such as iRORA, cRORA and the SIRE sign.
  • 6. Understand the appropriate referral pathways when you see AMD-related imaging biomarkers in your practice
  • 7. Understand the scientific principles behind gene augmentation and gene editing technologies.
  • 8. Learn about the currently available ocular gene therapies, and emerging technologies.
  • 9. Identify which patient groups are the most likely to benefit from gene therapy in the near future

Max points awarded: 3.00

Session Information

WAVE@home - AMD - Imaging, Classification and Advanced Therapeutics
Activity Type
Independent Learning with Assessment
Points for attending & Passing Assessment